LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

Search

Teleflex Inc

Fechado

SetorSaúde

124.44 -0.53

Visão Geral

Variação de preço das ações

24h

Atual

Mín

122.57

Máximo

125.3

Indicadores-chave

By Trading Economics

Rendimento

-531M

-409M

Vendas

132M

913M

P/E

Médio do Setor

28.636

76.798

Rendimento de Dividendos

1.07

Margem de lucro

-44.785

Funcionários

14,100

EBITDA

-546M

-323M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+9.67% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.07%

2.37%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

171M

5.6B

Abertura anterior

124.97

Fecho anterior

124.44

Sentimento de Notícias

By Acuity

8%

92%

3 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bearish Evidence

Teleflex Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

18 de dez. de 2025, 23:54 UTC

Ações em Alta

Stocks to Watch: Nike, Cassava Sciences, KB Home

18 de dez. de 2025, 23:51 UTC

Ganhos

Nike Sales Tick Up in 2Q; China Weakness Persists -- Update

18 de dez. de 2025, 23:39 UTC

Grandes Movimentos do Mercado

Cassava Sciences Shares Fall After FDA Places Hold on Epilepsy Drug Trial

18 de dez. de 2025, 22:57 UTC

Aquisições, Fusões, Aquisições de Empresas

TikTok Signs Agreement for Sale of U.S. Unit, Axios Reports, Citing a Memo

18 de dez. de 2025, 21:40 UTC

Ganhos

Nike Sales Tick Up, But China Weakness Persists

18 de dez. de 2025, 23:45 UTC

Conversa de Mercado

Gold Steady, Supported by Fed Rate-Cut Prospects -- Market Talk

18 de dez. de 2025, 23:37 UTC

Conversa de Mercado
Ganhos

Nike 2Q Results Fail to Convince Investors of Recovery -- Market Talk

18 de dez. de 2025, 23:36 UTC

Conversa de Mercado

Nikkei May Rise, Tracking Wall Street's Rally -- Market Talk

18 de dez. de 2025, 23:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: Impact on Consolidated Results for FY Ending March 2026 Likely to be Immaterial

18 de dez. de 2025, 23:02 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: To Acquire 4,448 Common Shares, 13,771 Preferred Shares of Co.

18 de dez. de 2025, 23:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: Investment to Strengthen Recovery Network in U.S.

18 de dez. de 2025, 22:59 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: Investment to Contribute to Expanding Collection Volume of Secondary Raw Material

18 de dez. de 2025, 22:58 UTC

Aquisições, Fusões, Aquisições de Empresas

SpaceX Could Go Public by Merging With EchoStar. It Isn't a Crazy Idea. -- Barrons.com

18 de dez. de 2025, 22:57 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: Elemental USA E-Waste Operates E-Waste Recycling Business in U.S.

18 de dez. de 2025, 22:56 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: To Acquire Portion of Shares of Elemental USA E-Waste & ITAD

18 de dez. de 2025, 22:55 UTC

Ganhos

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 de dez. de 2025, 21:59 UTC

Ganhos

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 de dez. de 2025, 21:50 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

18 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

18 de dez. de 2025, 21:35 UTC

Ganhos

FedEx's Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

18 de dez. de 2025, 21:31 UTC

Ganhos

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Europe, Middle East & Africa Rev $3.39B >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Greater China Rev Down 17% >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q EPS 53c >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Apparel Rev $3.91B >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Equipment Rev $550M >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q N Amer Rev $5.63B >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Footwear Rev $7.66B >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Asia Pacific & Latin America Rev Down 4% >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Greater China Rev $1.42B >NKE

Comparação entre Pares

Variação de preço

Teleflex Inc Previsão

Preço-alvo

By TipRanks

9.67% parte superior

Previsão para 12 meses

Média 137.2 USD  9.67%

Máximo 155 USD

Mínimo 122 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Teleflex Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

7 ratings

1

Comprar

5

Manter

1

Vender

Pontuação Técnica

By Trading Central

122.73 / 135.75Suporte e Resistência

Curto Prazo

Very Strong Bearish Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

No Evidence

Sentimento

By Acuity

3 / 374 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Teleflex Inc

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
help-icon Live chat